FDA Import Refusal SCS-9331616-8/41/1 — GLAXO
The FDA refused shipment SCS-9331616-8/41/1 from GLAXO (India) on Apr 14, 2025. The refused product falls under Drugs and Biologics — ACETAMINOPHEN (ANALGESIC). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Apr 14, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60LCB01 ACETAMINOPHEN (ANALGESIC)
- Charges
- 75